IL-2 induces STAT4 activation in primary NK cells and NK cell lines, but not in T cells

被引:0
|
作者
Wang, KS [1 ]
Ritz, J [1 ]
Frank, DA [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Med, Dana Farber Canc Inst,Dept Adult Oncol, Boston, MA 02115 USA
来源
JOURNAL OF IMMUNOLOGY | 1999年 / 162卷 / 01期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-2 exerts potent but distinct functional effects on two critical cell populations of the immune system, T cells and NK cells. Whereas IL-2 leads to proliferation in both cell types, it enhances cytotoxicity primarily in NR cells. In both T cells and NK cells, IL-2 induces the activation of STAT1, STAT3, and STAT5. Given this similarity in intracellular signaling, the mechanism underlying the distinct response to IL-2 in T cells and NK cells is not clear. In this study, we show that in primary NK cells and NK cell lines, in addition to the activation of STAT1 and STAT5, IL-2 induces tyrosine phosphorylation of STAT4, a STAT previously reported to be activated only in response to IL-12 and IFN-alpha. This activation of STAT4 in response to IL-2 is not due to the autocrine production of IL-12 or IFN-alpha. STAT4 activated in response to IL-2 is able to bind to a STAT-binding DNA sequence, suggesting that in NK cells IL-2 is capable of activating target genes through phosphorylation of STAT4. IL-2 induces the activation of Jak2 uniquely in NK cells, which may underlie the ability of IL-2 to activate STAT4 only in these cells. Although the activation of STAT4 in response to IL-2 occurs in primary resting and activated NK cells, it does not occur in primary resting T cells or mitogen-activated T cells. The unique activation of the STAT4-signaling pathway in NK cells may underlie the distinct functional effect of IL-2 on this cell population.
引用
收藏
页码:299 / 304
页数:6
相关论文
共 50 条
  • [41] Mechanisms of NK cell activation: CD4+ T cells enter the scene
    Bihl, Franck
    Germain, Claire
    Luci, Carmelo
    Braud, Veronique M.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2011, 68 (21) : 3457 - 3467
  • [42] Mechanisms of NK cell activation: CD4+ T cells enter the scene
    Franck Bihl
    Claire Germain
    Carmelo Luci
    Veronique M. Braud
    Cellular and Molecular Life Sciences, 2011, 68 : 3457 - 3467
  • [43] IL-2 mediates NK cell proliferation but not hyperactivity
    Richa Sharma
    Asmita Das
    Immunologic Research, 2018, 66 : 151 - 157
  • [44] IL-2 mediates NK cell proliferation but not hyperactivity
    Sharma, Richa
    Das, Asmita
    IMMUNOLOGIC RESEARCH, 2018, 66 (01) : 151 - 157
  • [45] Enhanced anti-metastatic efficacy of IL-2 activated NK(A-NK) cells with novel benzothiazoles
    Goldfarb, RH
    Kitson, RP
    Brunson, KW
    Yoshino, K
    Hirota, N
    Kirii, Y
    Kotera, Y
    Inoue, Y
    Ohashi, M
    ANTICANCER RESEARCH, 1999, 19 (3A) : 1663 - 1667
  • [46] In Vitro Activation of NK Cells From Regional Lymph Nodes of Melanoma Patients With IL-2 and IL-15
    Vuletic, A.
    Jovanic, I.
    Nikolic, S.
    Tanic, N.
    Konjevic, G.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S266 - S266
  • [47] Identification of matrix metalloproteinases(MMPs) produced by rat and mouse IL-2 activated NK(A-NK) cells
    Kim, MH
    Kitson, RP
    Xue, Y
    Goldfarb, RH
    FASEB JOURNAL, 1999, 13 (07): : A1536 - A1536
  • [48] CD2 stimulation leads to the delayed and prolonged activation of STAT1 in T cells but not NK cells
    Mahajan, S
    Gollob, JA
    Ritz, J
    Frank, DA
    EXPERIMENTAL HEMATOLOGY, 2001, 29 (02) : 209 - 220
  • [49] Gene expression analysis of recipient NK cells after Liver Transplantation demonstrates downregulation of STAT4
    Jamil, Khaleel M.
    Cheent, Kuldeep S.
    Heneghan, Michael A.
    Purbhoo, Marco
    Khakoo, Salim I.
    HEPATOLOGY, 2013, 58 : 410A - 410A
  • [50] MAINTENANCE THERAPY WITH CEPLENE® (HISTAMINE DIHYDROCHLORIDE) AND PROLEUKIN S® (IL-2) LEADS TO ACTIVATION OF NK CELLS BUT ALSO EXPANSION OF T REGULATORY CELLS IN AML
    Altmann, T.
    Lichtenegger, F.
    Beck, B.
    Krupka, C.
    Schnorfeil, F.
    Hiddemann, W.
    Fiegl, M.
    Subklewe, M.
    HAEMATOLOGICA, 2013, 98 : 525 - 525